Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Theophylline	O
/	O
nitroglycerin	O
/	O
Morphine	O
/	O
Codeine	O
/	O
Metal	O
Can-Brush	O
Top	O
Applicator	O
/	O
Augmentin	O
/	O
tramadol	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Abdominal	O
Pain,	O
Nausea,	O
Vomiting	O
x	O
1	O
day	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None.	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
F	O
with	O
a	O
PMH	O
OF	O
CAD	O
who	O
presents	O
with	O
anorexia,	O
chest	O
pain,	O
and	O
upper	O
epigastric	O
chest	O
pain.	O
Patient	O
reports	O
feeling	O
dizzy	O
around	O
5	O
___	O
yesterday.	O
She	O
did	O
not	O
eat	O
much	O
the	O
day	O
prior	O
due	O
to	O
a	O
poor	O
appetite.	O
She	O
went	O
to	O
the	O
bathroom	O
to	O
have	O
a	O
bowel	O
movement	O
and	O
while	O
sitting	O
on	O
the	O
toilet	O
vomited	O
"orange,	O
grapefruit"	O
Denies	O
constipation.	B-Constipation
Stool	O
reportedly	O
"normal"	O
No	O
new	O
foods,	O
no	O
sick	O
contacts.	O
She	O
reports	O
having	O
sharp,	O
severe,	O
cramping	O
pain	O
under	O
her	O
L	O
breast.	O
Reports	O
this	O
pain	O
was	O
different	O
from	O
when	O
she	O
had	O
an	O
MI	O
nearly	O
a	O
year	O
ago.	O
Reports	O
3	O
weeks	O
of	O
coughing	O
with	O
clear	O
occasional	O
productive	O
sputum	O
and	O
intermittent	O
chills.	O
She	O
was	O
seen	O
by	O
her	O
PCP	O
on	O
___	O
and	O
started	O
on	O
a	O
prednisone	O
taper	O
for	O
asthma.	O
She	O
was	O
last	O
hospitalized	O
for	O
asthma	O
last	O
year,	O
but	O
has	O
been	O
getting	O
steroid	O
tapers	O
intermittently.	O
Denies	O
fevers/chills.	O
No	O
headaches,	O
shortness	O
of	O
breath,	O
constipation,	B-Constipation
dysuria,	O
___	O
swelling.	O
No	O
sick	O
contacts,	O
no	O
recent	O
travel.	O
In	O
the	O
ED,	O
patient	O
notably	O
had	O
severe	O
pain,	O
leukocytosis	O
to	O
17.3,	O
lactate	O
2.5,	O
LFTs	O
elevated,	O
and	O
a	O
RUQ	O
scan	O
showing	O
cholelithiasis	O
w/out	O
cholecystitis.	O
CTA	O
with	O
no	O
PE,	O
no	O
acute	O
findings	O
in	O
the	O
torso.	O
Moderate	O
stool	B-Constipation
burden	B-Constipation
in	O
ascending/transverse	O
colon.	O
Patient	O
seen	O
by	O
ACS	O
-	O
no	O
acute	O
surgical	O
needs.	O
When	O
seen	O
on	O
the	O
floors,	O
patient's	O
chest	O
pain	O
had	O
resolved	O
and	O
just	O
felt	O
"soreness"	O
in	O
her	O
abdomen.	O
No	O
more	O
episodes	O
of	O
vomiting	O
or	O
stool.	O
ROS:	O
Pertinent	O
positives	O
and	O
negatives	O
as	O
noted	O
in	O
the	O
HPI.	O
All	O
other	O
systems	O
were	O
reviewed	O
and	O
are	O
negative	O
Past	O
Medical	O
History:	O
-Severe	O
Asthma:	O
never	O
intubated	O
-Allergies	O
-GERD	O
-Obstructive	O
sleep	O
apnea,	O
on	O
home	O
CPAP	O
via	O
face	O
mask	O
-Hypertension	O
-Osteoporosis	O
-Osteoarthritis	O
-NSTEMI	O
s/p	O
DES	O
to	O
LCx	O
-hyperlipidemia	O
-recurrent	O
sinusitis	O
Social	O
History:	O
___	O
Family	O
History:	O
Mother-	O
died	O
___	O
yo	O
of	O
cerebral	B-Intracranial_haemorrhage
aneurysm;	B-Intracranial_haemorrhage
PMH-	O
HBP	O
Father-	O
died	O
___	O
yo	O
of	O
MI	O
5	O
Brothers-	O
1	O
died	O
of	O
MI,	O
2	O
died	O
in	O
accidents,	O
1	O
died	O
of	O
MI,	O
1	O
brother	O
w/	O
CAD	O
8	O
Sisters-	O
1	O
died	O
liver	O
disease	O
(h/o	O
EtOH	O
abuse),	O
6	O
alive	O
&	O
well,	O
1	O
w/	O
BA	O
Physical	O
Exam:	O
Admission	O
Physical	O
Exam	O
VITALS:	O
98.6	O
PO	O
109	O
/	O
58	O
L	O
80	O
20	O
98	O
RA	O
GENERAL:	O
Alert	O
and	O
in	O
no	O
apparent	O
distress	O
EYES:	O
Anicteric,	O
pupils	O
equally	O
round	O
ENT:	O
Ears	O
and	O
nose	O
without	O
visible	O
erythema,	O
masses,	O
or	O
trauma.	O
Oropharynx	O
without	O
visible	O
lesion,	O
erythema	O
or	O
exudate	O
CV:	O
RRR,	O
no	O
mrg;	O
no	O
ttp	O
under	O
L	O
breast	O
RESP:	O
diffuse	O
wheezing	O
GI:	O
Abdomen	O
soft,	O
non-distended,	O
mild	O
ttp	O
in	O
R	O
middle	O
abd.	O
Bowel	O
sounds	O
present.	O
No	O
HSM	O
GU:	O
No	O
suprapubic	O
fullness	O
or	O
tenderness	O
to	O
palpation	O
MSK:	O
Neck	O
supple,	O
moves	O
all	O
extremities,	O
strength	O
grossly	O
full	O
and	O
symmetric	O
bilaterally	O
in	O
all	O
limbs	O
SKIN:	O
No	O
rashes	O
or	O
ulcerations	O
noted	O
NEURO:	O
Alert,	O
oriented,	B-Delirium
face	O
symmetric,	O
gaze	O
conjugate	O
with	O
EOMI,	O
speech	O
fluent,	O
moves	O
all	O
limbs,	O
sensation	O
to	O
light	O
touch	O
grossly	O
intact	O
throughout	O
PSYCH:	O
pleasant,	O
appropriate	O
affect	O
.	O
.	O
Discharge	O
Exam:	O
VITALS:	O
98.4	O
PO	O
155	O
/	O
83	O
R	O
Lying	O
87	O
16	O
100	O
Ra	O
WT:	O
77.1	O
kg	O
(standing	O
on	O
___	O
GENERAL:	O
Alert	O
and	O
in	O
no	O
apparent	O
distress	O
sitting	O
up	O
in	O
chair	O
EYES:	O
Anicteric,	O
EOMI	O
ENT:	O
MMM,	O
normal	O
vocal	O
quality	O
CV:	O
RR,	O
no	O
m/r/g	O
RESP:	O
diffuse	O
wheezing	O
with	O
prolonged	O
expiratory	O
phase	O
is	O
unchanged	O
the	O
past	O
3	O
days,	O
normal	O
WOB	O
without	O
accessory	O
muscle	O
use,	O
speaking	O
in	O
full	O
sentences	O
GI:	O
Abdomen	O
soft,	O
non-distended,	O
not	O
tender	O
to	O
palpation,	O
BS+.	O
No	O
stigmata	O
of	O
chronic	O
liver	O
disease	O
(no	O
caput	O
medusa,	O
no	O
palmar	O
erythema)	O
MSK:	O
left	O
shoulder	O
aROM	O
is	O
limited	O
(chronic	O
per	O
pt.)	O
SKIN:	O
No	O
rashes	O
or	O
ulcerations	O
noted	O
NEURO:	O
Alert,	O
oriented,	B-Delirium
face	O
symmetric,	O
gaze	O
conjugate	O
with	O
EOMI,	O
speech	O
fluent,	O
moves	O
all	O
limbs,	O
no	O
asterixis	O
or	O
tremor;	O
poor	O
short-term	O
recall	O
PSYCH:	O
calm,	O
appropriate	O
affect	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
------------------	O
WBC	O
17.3	O
to	O
12.7/HB	O
10.4	O
(MCV	O
95)/Plt	O
279	O
Na	O
142/K	O
4.0/Cl	O
100/HCO3	O
26/BUN	O
15/Cr	O
0.6<Glu	O
112	O
AST	O
843/ALT	O
623/AP	O
141/Tbili	O
1.4/DBil	O
Lipase:	O
32	O
Trop	O
neg	O
.	O
NOTABLE	O
STUDIES	O
---------------	O
Trop	O
neg	O
x	O
3	O
Hep	O
panel	O
negative	O
Serum	O
Tylenol	O
level:	O
7	O
(on	O
___	O
AMA:	O
negative	O
___:	O
negative	O
CMV	O
Ab:	O
pending	O
EBV	O
Ab:	O
positive	O
IgG's,	O
negative	O
IgM	O
(consistent	O
with	O
prior	O
exposure)	O
.	O
IMAGING	O
---------------	O
CXR	O
(___):	O
AP	O
portable	O
upright	O
view	O
of	O
the	O
chest.	O
Minimal	O
left	O
basal	O
atelectasis	O
is	O
noted.	O
The	O
heart	O
is	O
top-normal	O
in	O
size.	O
Mediastinal	O
contour	O
is	O
normal.	O
No	O
focal	O
consolidation	O
concerning	O
for	O
pneumonia.	B-Lower_respiratory_tract_infection
No	O
large	O
effusion	O
or	O
pneumothorax.	O
Imaged	O
bony	O
structures	O
are	O
intact.	O
No	O
free	O
air	O
below	O
the	O
right	O
hemidiaphragm	O
seen.	O
Left	O
glenohumeral	O
arthritis	O
again	O
noted,	O
severe.	O
CT	O
A/P	O
(___):	O
"no	O
pulmonary	O
embolism	O
or	O
aortic	O
abnormality,	O
no	O
acute	O
findings	O
in	O
the	O
torso,	O
moderate	O
stool	B-Constipation
burden	B-Constipation
in	O
ascending	O
and	O
transverse	O
colon"	O
RUQ	O
u/s	O
(___):	O
"Cholelithiasis	O
without	O
evidence	O
of	O
cholecystitis."	O
CTA	O
(___):	O
"1.	O
No	O
pulmonary	O
embolism	O
or	O
aortic	O
abnormality.	O
2.	O
Diffuse	O
bronchitis.	O
3.	O
Moderate	O
stool	B-Constipation
burden	B-Constipation
in	O
the	O
ascending	O
and	O
transverse	O
colon.	O
4.	O
Small	O
hiatal	O
hernia"	O
MRCP	O
(___):	O
"IMPRESSION:	O
1.	O
Cholelithiasis	O
with	O
a	O
few	O
stones	O
in	O
the	O
cystic	O
duct;	O
however,	O
no	O
evidence	O
of	O
acute	O
cholecystitis.	O
No	O
evidence	O
of	O
CBD	O
stones.	O
No	O
evidence	O
of	O
intra	O
or	O
extrahepatic	O
biliary	O
dilatation.	O
2.	O
Subcentimeter	O
pancreatic	O
cysts,	O
likely	O
side	O
branch	O
IPMN's	O
for	O
which	O
no	O
follow-up	O
is	O
recommended."	O
.	O
MICRO	O
---------------	O
___	O
BCx:	O
No	O
growth	O
(final)	O
___	O
UCx:	O
No	O
significant	O
growth	O
(final)	O
.	O
DISCHARGE	O
LABS	O
----------------	O
___	O
05:39AM	O
BLOOD	O
WBC-11.1*	O
RBC-3.65*	O
Hgb-11.3	O
Hct-34.7	O
MCV-95	O
MCH-31.0	O
MCHC-32.6	O
RDW-15.2	O
RDWSD-53.1*	O
Plt	O
___	O
___	O
05:39AM	O
BLOOD	O
___	O
PTT-39.8*	O
___	O
___	O
05:39AM	O
BLOOD	O
Glucose-83	O
UreaN-12	O
Creat-0.6	O
Na-144	O
K-3.9	O
Cl-105	O
HCO3-23	O
AnGap-16	O
___	O
05:39AM	O
BLOOD	O
ALT-493*	O
AST-81*	O
AlkPhos-206*	O
TotBili-0.7	O
___	O
05:39AM	O
BLOOD	O
Albumin-3.8	O
Calcium-9.4	O
Phos-2.9	O
Mg-2.___	O
year	O
old	O
F	O
with	O
a	O
PMH	O
OF	O
CAD	O
who	O
presents	O
with	O
anorexia,	O
chest	O
pain,	O
and	O
epigastric	O
chest	O
pain	O
and	O
subsequently	O
developed	O
significant	O
transaminitis.	O
#Transaminitis	O
-	O
hepatocellular	O
pattern	O
and	O
RUQ	O
pain	O
is	O
consistent	O
acute	O
hepatitis.	O
CTA	O
and	O
RUQ	O
U/S	O
w/no	O
s/s	O
cirrhosis,	O
thrombosis.	O
-	O
did	O
not	O
develop	O
any	O
evidence	O
of	O
acute	O
liver	O
failure	O
--	O
INR	O
1	O
--	O
no	O
evidence	O
of	O
ascites	O
--	O
no	O
evidence	O
of	O
hepatic	O
encephalopathy	O
-	O
DDx	O
includes:	O
DILI,	O
Ischemic/hypoxic	O
hepatitis,	O
autoimmune	O
hepatitis,	O
viral	O
hepatitis	O
(not	O
Hep	O
A,	O
B,	O
or	O
C	O
based	O
on	O
negative	O
serologies,	O
but	O
HSV,	O
VZV,	O
EBV,	O
CMV	O
or	O
other	O
viral	O
causes	O
are	O
possible),	O
choledocholithiasis	O
with	O
transient	O
obstruction	O
-	O
unlikely	O
___	O
disease	O
at	O
her	O
age	O
-	O
not	O
Hemochromatosis	O
given	O
her	O
recent	O
ferritin	O
of	O
99	O
-	O
trend	O
liver	O
enzymes	O
daily:	O
improving	O
-	O
trend	O
INR	O
daily:	O
normal	O
-	O
trend	O
bili	O
daily:	O
normal	O
-	O
given	O
hepatocellular	O
pattern	O
became	O
more	O
prominent,	O
ordered	O
studies	O
for	O
AIH,	O
viral	O
hepatitis	O
(EBV	O
&	O
CMV)	O
-	O
NEGATIVE	O
--	O
HSV	O
&	O
VZV	O
are	O
send	O
outs,	O
not	O
sending	O
since	O
liver	O
enzymes	O
are	O
improving	O
and	O
no	O
rashes	O
or	O
other	O
suggestive	O
findings	O
-	O
MRCP	O
showed	O
cholelithiasis	O
without	O
evidence	O
of	O
cholecystitis	O
or	O
choledocholithiasis	O
-	O
possible	O
causes	O
of	O
DILI	O
from	O
her	O
PAML:	O
-	O
statin	O
--stopped	O
her	O
home	O
atorvastatin	O
for	O
now,	O
not	O
resumed	O
on	O
discharge	O
(discussed	O
with	O
her	O
PCP,	O
___	O
-	O
aspirin	O
-	O
lisinopril	O
-	O
sertraline	O
-	O
mepolizumab	O
(d/w	O
Dr.	O
___	O
-	O
this	O
is	O
unlikely	O
given	O
that	O
it	O
is	O
not	O
cleared	O
by	O
the	O
liver)	O
-	O
umeclidinium	O
(maybe?	O
seems	O
unlikely)	O
-	O
unlikely	O
to	O
be	O
APAP-induced	O
DILI	O
given	O
she	O
reports	O
very	O
minimal	O
Tylenol	O
intake	O
and	O
Tylenol	O
level	O
wasn't	O
particularly	O
high	O
[]	O
Please	O
repeat	O
liver	O
enzymes	O
and	O
LFTs	O
in	O
~1	O
week	O
to	O
ensure	O
resolution	O
#	O
Cholelithiasis:	O
likely	O
the	O
source	O
of	O
her	O
episodic	O
RUQ	O
pain,	O
also	O
could	O
explain	O
transient	O
biliary	O
obstruction/transaminitis	O
-	O
Surgery	O
(ACS)	O
team	O
feels	O
she	O
would	O
likely	O
benefit	O
from	O
CCY,	O
but	O
feel	O
that	O
her	O
current	O
asthma	O
signs/sx's	O
make	O
her	O
a	O
poor	O
candidate	O
to	O
have	O
this	O
done	O
during	O
this	O
hospitalization.	O
They	O
will	O
f/u	O
with	O
her	O
in	O
clinic	O
and	O
plan	O
for	O
elective	O
CCY	O
once	O
her	O
asthma	O
is	O
under	O
better	O
control.	O
[]	O
needs	O
preoperative	O
pulmonary	O
optimization	O
[]	O
has	O
f/u	O
scheduled	O
in	O
General	O
Surgery	O
clinic	O
#Chest	O
Pain	O
#Upper	O
Epigastric	O
Pain	O
#Nausea/Vomiting/Abdominal	O
Pain	O
Differential	O
broad	O
initially,	O
but	O
most	O
likely	O
gallbladder	O
stone	O
that	O
may	O
have	O
passed	O
vs.	O
acute	O
hepatitis.	O
Considered	O
ACS	O
given	O
cardiac	O
history	O
but	O
troponins	O
neg	O
x3,	O
EKG	O
stable	O
and	O
CP	O
resolved.	O
CTA	O
w/	O
no	O
e/o	O
PE	O
or	O
aortic	O
dissection.	O
Does	O
have	O
substantial	O
stool/constipation	I-Constipation
possibly	O
contributing	O
to	O
her	O
pain.	O
-bowel	O
regimen:	O
docusate,	O
senna,	O
Miralax	O
-added	O
dulcolax	O
PO/PR	O
PRN	O
for	O
ongoing	O
constipation	B-Constipation
-constipation	I-Constipation
resolved	O
with	O
this	O
regimen	O
-low	O
dose	O
oxycodone	O
PRN	O
abdominal	O
pain	O
(since	O
Tylenol	O
and	O
NSAIDs	O
not	O
an	O
option	O
in	O
setting	O
of	O
possible	O
DILI	O
and	O
Tramadol	O
is	O
listed	O
as	O
allergy)	O
#CAD	O
s/p	O
stent	O
-continue	O
ASA	O
81	O
mg	O
daily	O
for	O
now,	O
no	O
longer	O
on	O
Plavix	O
-holding	O
home	O
statin	O
in	O
setting	O
of	O
transaminitis	O
--	O
will	O
not	O
plan	O
to	O
resume	O
statin	O
on	O
discharge	O
(discussed	O
with	O
PCP,	O
___	O
[]	O
Assess	O
for	O
resuming	O
statin	O
#Asthma:	O
severe,	O
with	O
recent	O
and	O
ongoing	O
exacerbation	O
-duonebs	O
q6h	O
-albuterol	O
q2h	O
PRN	O
-continue	O
prednisone	O
taper	O
started	O
on	O
day	O
before	O
admission	O
as	O
outpatient	O
at	O
40	O
mg;	O
plan	O
to	O
taper	O
10	O
mg	O
every	O
___	O
prednisone	O
to	O
20	O
mg	O
today;	O
continue	O
for	O
3	O
days,	O
then	O
10	O
mg	O
daily	O
until	O
follow	O
up	O
with	O
Dr.	O
___	O
montelukast	O
10	O
mg	O
daily	O
-continue	O
cetirizine	O
10	O
mg	O
PO	O
daily	O
-Incluse	O
Ellipta	O
not	O
on	O
formulary	O
-continue	O
mepolizumab	O
injections	O
as	O
an	O
OP	O
#Insomnia/Depression	O
-continue	O
sertraline	O
25	O
mg	O
PO	O
daily	O
#HTN:	O
held	O
home	O
BP	O
meds	O
I/s/o	O
poor	O
PO	O
intake	O
and	O
lower	O
BPs	O
initially	O
-held	O
home	O
lisinopril	O
10	O
mg	O
daily	O
in	O
setting	O
of	O
possible	O
DILI	O
during	O
hospitalization,	O
resumed	O
on	O
discharge	O
-resumed	O
home	O
HCTZ	O
on	O
day	O
of	O
discharge	O
given	O
BP	O
increasing	O
#	O
OSA	O
-	O
CPAP	O
at	O
night	O
during	O
hospitalization	O
-	O
have	O
emailed	O
Dr.	O
___	O
Dr.	O
___	O
to	O
alert	O
them	O
to	O
issue	O
of	O
patient	O
without	O
functioning	O
CPAP	O
-	O
I	O
suspect	O
that	O
untreated	O
OSA	O
contributes	O
to	O
several	O
things	O
which	O
she	O
has	O
chronically,	O
including	O
insomnia	O
and	O
headache	O
[]	O
Needs	O
assistance	O
obtaining	O
functional	O
CPAP	O
for	O
home	O
use	O
#	O
Headache	O
-	O
mild	O
but	O
persistent	O
-	O
avoiding	O
Tylenol	O
___	O
transaminitis	O
-	O
has	O
Tramadol	O
allergy	O
-	O
do	O
not	O
want	O
to	O
send	O
out	O
on	O
oxycodone	O
due	O
to	O
risk	O
of	O
respiratory	O
depression	O
(and	O
potentially	O
worsening	O
OSA)	O
-	O
will	O
give	O
Rx	O
for	O
very	O
low	O
dose	O
(200	O
mg)	O
ibuprofen	O
up	O
to	O
TID	O
(total	O
#10	O
tabs)	O
for	O
her	O
to	O
take	O
PRN	O
headache	O
================================	O
TRANSITIONAL	O
ISSUES	O
[]	O
Please	O
repeat	O
liver	O
enzymes	O
and	O
LFTs	O
in	O
~1	O
week	O
to	O
ensure	O
resolution	O
[]	O
Needs	O
assistance	O
obtaining	O
functional	O
CPAP	O
for	O
home	O
use	O
[]	O
Assess	O
for	O
resuming	O
statin	O
[]	O
needs	O
preoperative	O
pulmonary	O
optimization	O
[]	O
has	O
f/u	O
scheduled	O
in	O
General	O
Surgery	O
clinic	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
PredniSONE	O
40	O
mg	O
PO	O
DAILY	O
Start:	O
Today	O
-	O
___,	O
First	O
Dose:	O
STAT	O
This	O
is	O
dose	O
#	O
1	O
of	O
4	O
tapered	O
doses	O
2.	O
PredniSONE	O
30	O
mg	O
PO	O
DAILY	O
Start:	O
After	O
40	O
mg	O
DAILY	O
tapered	O
dose	O
This	O
is	O
dose	O
#	O
2	O
of	O
4	O
tapered	O
doses	O
3.	O
PredniSONE	O
20	O
mg	O
PO	O
DAILY	O
Start:	O
After	O
30	O
mg	O
DAILY	O
tapered	O
dose	O
This	O
is	O
dose	O
#	O
3	O
of	O
4	O
tapered	O
doses	O
4.	O
PredniSONE	O
10	O
mg	O
PO	O
DAILY	O
Start:	O
After	O
20	O
mg	O
DAILY	O
tapered	O
dose	O
This	O
is	O
dose	O
#	O
4	O
of	O
4	O
tapered	O
doses	O
5.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
6.	O
Lisinopril	O
10	O
mg	O
PO	O
DAILY	O
7.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
8.	O
Cetirizine	O
10	O
mg	O
PO	O
DAILY	O
9.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
10.	O
Ipratropium-Albuterol	O
Inhalation	O
Spray	O
1	O
INH	O
IH	O
Q6H:PRN	O
shortness	O
of	O
breath	O
11.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
12.	O
Sertraline	O
25	O
mg	O
PO	O
DAILY	O
13.	O
Montelukast	O
10	O
mg	O
PO	O
DAILY	O
14.	O
Hydrochlorothiazide	O
12.5	O
mg	O
PO	O
DAILY	O
15.	O
Incruse	O
Ellipta	O
(umeclidinium)	O
62.5	O
mcg/actuation	O
inhalation	O
Q12H	O
Discharge	O
Medications:	O
1.	O
Bisacodyl	O
10	O
mg	O
PO/PR	O
DAILY:PRN	O
constipation	B-Constipation
RX	O
*bisacodyl	O
[Dulcolax	O
(bisacodyl)]	O
5	O
mg	O
2	O
tablet(s)	O
by	O
mouth	O
daily:PRN	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
2.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
RX	O
*docusate	O
sodium	O
[Colace]	O
100	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*60	O
Capsule	O
Refills:*3	O
3.	O
Ibuprofen	O
200	O
mg	O
PO	O
Q8H:PRN	O
Headache	O
Duration:	O
3	O
Days	O
Do	O
not	O
take	O
more	O
than	O
3	O
tabs	O
in	O
a	O
day.	O
RX	O
*ibuprofen	O
[Advil]	O
200	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
TID:PRN	O
Disp	O
#*12	O
Tablet	O
Refills:*0	O
4.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
RX	O
*sennosides	O
[senna]	O
8.6	O
mg	O
1	O
tab	O
by	O
mouth	O
BID:PRN	O
Disp	O
#*60	O
Tablet	O
Refills:*3	O
5.	O
PredniSONE	O
20	O
mg	O
PO	O
DAILY	O
Duration:	O
2	O
Days	O
Start:	O
After	O
30	O
mg	O
DAILY	O
tapered	O
dose	O
This	O
is	O
dose	O
#	O
3	O
of	O
4	O
tapered	O
doses	O
Tapered	O
dose	O
-	O
DOWN	O
6.	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q2H:PRN	O
SOB/wheezing	O
7.	O
albuterol	O
sulfate	O
90	O
mcg/actuation	O
inhalation	O
TID:PRN	O
SOB/wheezing	O
8.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
9.	O
Cetirizine	O
10	O
mg	O
PO	O
DAILY	O
10.	O
Hydrochlorothiazide	O
12.5	O
mg	O
PO	O
DAILY	O
11.	O
Incruse	O
Ellipta	O
(umeclidinium)	O
62.5	O
mcg/actuation	O
inhalation	O
Q12H	O
12.	O
Ipratropium-Albuterol	O
Neb	O
1	O
NEB	O
NEB	O
Q6H	O
13.	O
Lisinopril	O
10	O
mg	O
PO	O
DAILY	O
14.	O
mepolizumab	O
100	O
mg	O
subcutaneous	O
ASDIR	O
15.	O
Montelukast	O
10	O
mg	O
PO	O
DAILY	O
16.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
17.	O
PredniSONE	O
10	O
mg	O
PO	O
DAILY	O
Start:	O
After	O
20	O
mg	O
DAILY	O
tapered	O
dose	O
This	O
is	O
dose	O
#	O
4	O
of	O
4	O
tapered	O
doses	O
RX	O
*prednisone	O
10	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
18.	O
Sertraline	O
25	O
mg	O
PO	O
DAILY	O
19.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
20.	O
HELD-	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Atorvastatin	O
until	O
instructed	O
to	O
do	O
so	O
by	O
Dr.	O
___	O
___	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
___	O
Diagnosis:	O
Cholelithiasis	O
Transaminitis	O
Severe	O
asthma	O
with	O
acute	O
exacerbation	O
Constipation	B-Constipation
CAD	O
HTN	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	O
requires	O
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
You	O
were	O
admitted	O
for	O
chest	O
pain.	O
We	O
did	O
an	O
ultrasound	O
that	O
showed	O
gallstones,	O
which	O
may	O
have	O
been	O
the	O
source	O
of	O
your	O
pain,	O
nausea,	O
and	O
vomiting.	O
Your	O
liver	O
was	O
also	O
temporarily	O
inflamed	O
as	O
a	O
result	O
of	O
either	O
a	O
passed	O
gallstone	O
or	O
possibly	O
one	O
of	O
your	O
medications.	O
You	O
underwent	O
an	O
MRI	O
of	O
the	O
abdomen,	O
which	O
showed	O
gallstones	O
in	O
your	O
gallbladder	O
and	O
cystic	O
duct,	O
but	O
no	O
evidence	O
of	O
obstruction	O
of	O
your	O
bile	O
ducts.	O
For	O
your	O
intermittent	O
episodes	O
of	O
right-sided	O
abdominal	O
pain	O
(lasting	O
___	O
minutes),	O
we	O
suspect	O
this	O
is	O
from	O
the	O
presence	O
of	O
gallstones	O
(called	O
"symptomatic	O
cholelithiasis").	O
The	O
surgery	O
doctors	O
recommend	O
that	O
___	O
have	O
your	O
gallbladder	O
surgically	O
removed	O
once	O
your	O
asthma	O
is	O
under	O
better	O
control.	O
In	O
the	O
meantime,	O
please	O
avoid	O
fatty,	O
fried	O
food	O
in	O
your	O
diet	O
and	O
stay	O
well	O
hydrated.	O
Please	O
plan	O
to	O
follow-up	O
in	O
general	O
surgery	O
clinic	O
in	O
___	O
weeks	O
to	O
be	O
re-evaluated	O
for	O
possible	O
surgery.	O
If	O
you	O
develop	O
right-sided	O
abdominal	O
pain	O
that	O
does	O
not	O
go	O
away	O
for	O
more	O
than	O
an	O
hour,	O
or	O
is	O
associated	O
with	O
fever,	O
shaking	O
chills,	O
vomiting,	O
or	O
jaundice	O
(yellowing	O
of	O
the	O
skin),	O
please	O
seek	O
immediate	O
medical	O
attention.	O
For	O
your	O
liver	O
inflammation,	O
we	O
do	O
not	O
know	O
for	O
certain	O
1)	O
if	O
this	O
was	O
caused	O
by	O
a	O
medication,	O
and	O
2)	O
if	O
so,	O
which	O
medication	O
it	O
was.	O
We	O
have	O
stopped	O
one	O
of	O
your	O
home	O
medications:	O
atorvastatin	O
(Lipitor).	O
Please	O
do	O
NOT	O
resume	O
taking	O
atorvastatin	O
(Lipitor)	O
until	O
told	O
to	O
do	O
so	O
by	O
Dr.	O
___.	O
Please	O
plan	O
to	O
have	O
your	O
liver	O
labs	O
rechecked	O
in	O
~___.	O
For	O
your	O
asthma,	O
you	O
were	O
treated	O
with	O
continuation	O
of	O
your	O
prednisone	O
taper.	O
You	O
are	O
going	O
to	O
take	O
20	O
mg	O
of	O
prednisone	O
each	O
day	O
for	O
the	O
next	O
2	O
days,	O
then	O
take	O
10	O
mg	O
daily	O
until	O
you	O
see	O
Dr.	O
___,	O
NP	O
in	O
pulmonology	O
clinic.	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
and	O
we	O
wish	O
you	O
a	O
full	O
and	O
speedy	O
recovery.	O
Sincerely,	O
The	O
___	O
Medicine	O
Team	O
Followup	O
Instructions:	O
___	O

